AVEO Oncology Revenue

Biotechnology Research • Boston, Massachusetts, United States • 101-200 Employees

AVEO Oncology revenue & valuation

Annual revenue	$94,400,000
Revenue per employee	$484,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$301,900,000
Total funding	$55,200,000

Key Contact at AVEO Oncology

Michael Bailey

President and Chief Executive Officer

Mobile @aveooncology.com

Company overview

Headquarters	30 Winter St, 3rd Floor, Boston, Massachusetts 02108, US
Phone number	+18574000101
Website	aveooncology.com
NAICS	541714
SIC	283
Keywords	Oncology
Founded	2001
Employees	101-200
Socials

AVEO Oncology Email Formats

AVEO Oncology uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@aveooncology.com), used 51.4% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@aveooncology.com	51.4%
{first initial}{last name}	jdoe@aveooncology.com	43.6%
{last name}{last name}	doedoe@aveooncology.com	4.3%

About AVEO Oncology

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA® (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Manager

Director

Entry

Employees by Department

AVEO Oncology has 110 employees across 13 departments.

Departments

Number of employees

Funding Data

Explore AVEO Oncology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-04-22	14	$55,200,000

Funding Insights

$55,200,000

Total funding amount

$55,200,000

Most recent funding amount

Number of funding rounds

AVEO Oncology Tech Stack

Discover the technologies and tools that power AVEO Oncology's digital infrastructure, from frameworks to analytics platforms.

Modernizr

JavaScript libraries

Ninja Forms

Form builders

Marionette.js

JavaScript frameworks

Underscore.js

JavaScript libraries

PWA

Miscellaneous

Microsoft 365

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

AVEO Oncology is located in Boston, Massachusetts, US.

You can reach AVEO Oncology at +18574000101.

AVEO Oncology generates an estimated annual revenue of $94,319,000. This revenue figure reflects the company's market position and business performance in its industry.

AVEO Oncology has an estimated valuation of $301,900,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AVEO Oncology was founded in 2001, making it 25 years old. The company has established itself as a significant player in its industry over this time.

AVEO Oncology has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

AVEO Oncology has raised a total of $55,200,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at AVEO Oncology

Michael Bailey

President and Chief Executive Officer

Mobile @aveooncology.com

4.8

40,000 users